Youcare Pharmaceutical Group Co., Ltd. (SHA:688658)
China
· Delayed Price · Currency is CNY 20.51
-0.19 (-0.92%)
Jun 18, 2025, 2:45 PM CST
SHA:688658 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Operating Revenue | 3,377 | 3,767 | 4,183 | 4,521 | 4,942 | 4,241 | Upgrade
|
| Other Revenue | 13.47 | 13.47 | 13.63 | 20.97 | 23.84 | 98.32 | Upgrade
|
| Revenue | 3,390 | 3,781 | 4,196 | 4,542 | 4,966 | 4,339 | Upgrade
|
| Revenue Growth (YoY) | -15.99% | -9.90% | -7.61% | -8.53% | 14.45% | 1.20% | Upgrade
|
| Cost of Revenue | 1,503 | 1,640 | 1,622 | 1,669 | 1,556 | 1,504 | Upgrade
|
| Gross Profit | 1,887 | 2,141 | 2,574 | 2,873 | 3,410 | 2,835 | Upgrade
|
| Selling, General & Admin | 1,376 | 1,526 | 1,983 | 2,213 | 2,552 | 2,181 | Upgrade
|
| Research & Development | 385.98 | 374.31 | 351.88 | 344.42 | 200.03 | 127.89 | Upgrade
|
| Other Operating Expenses | 30.25 | 32.45 | 38.75 | 54.32 | 63.74 | 51.13 | Upgrade
|
| Operating Expenses | 1,788 | 1,927 | 2,360 | 2,633 | 2,836 | 2,355 | Upgrade
|
| Operating Income | 99.28 | 213.69 | 214.88 | 240 | 574.2 | 480.25 | Upgrade
|
| Interest Expense | -22.61 | -22.4 | -13.21 | -4.7 | -3.47 | -25.07 | Upgrade
|
| Interest & Investment Income | 14.73 | 17.62 | 23.4 | 28.27 | 35.18 | 2.04 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.94 | 0.94 | 1.33 | 10.19 | 6.57 | -13.05 | Upgrade
|
| Other Non Operating Income (Expenses) | -38.43 | -38.64 | -1.24 | -1.08 | -1.18 | -3.5 | Upgrade
|
| EBT Excluding Unusual Items | 53.92 | 171.22 | 225.15 | 272.68 | 611.3 | 440.67 | Upgrade
|
| Gain (Loss) on Sale of Investments | 2.34 | 2.34 | -0.69 | 2.89 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.86 | -1.86 | -2.77 | -9.73 | -5.27 | -2.67 | Upgrade
|
| Asset Writedown | -54.42 | -33.57 | -21.78 | - | -19.17 | - | Upgrade
|
| Other Unusual Items | 14.23 | 14.23 | 23.36 | 83.68 | 42.41 | 57.13 | Upgrade
|
| Pretax Income | 14.21 | 152.36 | 223.27 | 349.53 | 629.27 | 495.14 | Upgrade
|
| Income Tax Expense | 11.59 | 31.11 | 35.77 | 10.62 | 85.55 | 51.51 | Upgrade
|
| Earnings From Continuing Operations | 2.62 | 121.25 | 187.49 | 338.91 | 543.72 | 443.63 | Upgrade
|
| Minority Interest in Earnings | 2.52 | 2.47 | -2.7 | -3.72 | 1.59 | -1.49 | Upgrade
|
| Net Income | 5.14 | 123.72 | 184.8 | 335.18 | 545.32 | 442.14 | Upgrade
|
| Net Income to Common | 5.14 | 123.72 | 184.8 | 335.18 | 545.32 | 442.14 | Upgrade
|
| Net Income Growth | -96.95% | -33.05% | -44.87% | -38.53% | 23.34% | 54.89% | Upgrade
|
| Shares Outstanding (Basic) | 438 | 442 | 451 | 453 | 451 | 359 | Upgrade
|
| Shares Outstanding (Diluted) | 438 | 442 | 451 | 453 | 451 | 359 | Upgrade
|
| Shares Change (YoY) | -3.46% | -1.97% | -0.49% | 0.51% | 25.37% | -0.52% | Upgrade
|
| EPS (Basic) | 0.01 | 0.28 | 0.41 | 0.74 | 1.21 | 1.23 | Upgrade
|
| EPS (Diluted) | 0.01 | 0.28 | 0.41 | 0.74 | 1.21 | 1.23 | Upgrade
|
| EPS Growth | -96.85% | -31.71% | -44.59% | -38.84% | -1.63% | 55.70% | Upgrade
|
| Free Cash Flow | 47.8 | 79.64 | 288.01 | -669.13 | 314.75 | 570.94 | Upgrade
|
| Free Cash Flow Per Share | 0.11 | 0.18 | 0.64 | -1.48 | 0.70 | 1.59 | Upgrade
|
| Dividend Per Share | - | - | 0.200 | 1.100 | 0.680 | 0.450 | Upgrade
|
| Dividend Growth | - | - | -81.82% | 61.77% | 51.11% | - | Upgrade
|
| Gross Margin | 55.66% | 56.62% | 61.35% | 63.25% | 68.67% | 65.34% | Upgrade
|
| Operating Margin | 2.93% | 5.65% | 5.12% | 5.28% | 11.56% | 11.07% | Upgrade
|
| Profit Margin | 0.15% | 3.27% | 4.40% | 7.38% | 10.98% | 10.19% | Upgrade
|
| Free Cash Flow Margin | 1.41% | 2.11% | 6.86% | -14.73% | 6.34% | 13.16% | Upgrade
|
| EBITDA | 302.2 | 409.65 | 383.01 | 394.15 | 709.47 | 611.88 | Upgrade
|
| EBITDA Margin | 8.91% | 10.84% | 9.13% | 8.68% | 14.29% | 14.10% | Upgrade
|
| D&A For EBITDA | 202.92 | 195.96 | 168.13 | 154.15 | 135.28 | 131.64 | Upgrade
|
| EBIT | 99.28 | 213.69 | 214.88 | 240 | 574.2 | 480.25 | Upgrade
|
| EBIT Margin | 2.93% | 5.65% | 5.12% | 5.28% | 11.56% | 11.07% | Upgrade
|
| Effective Tax Rate | 81.53% | 20.42% | 16.02% | 3.04% | 13.59% | 10.40% | Upgrade
|
| Revenue as Reported | 3,390 | 3,781 | 4,196 | 4,542 | 4,966 | 4,339 | Upgrade
|
| Advertising Expenses | - | 4.75 | 14.7 | 18.36 | - | 0.53 | Upgrade
|
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.